Dettagli per singolo studio

DEC-NET Serial number GB275

Published online	07/07/2004 11.51.00
Last updated	02/08/2005 12.33.24

Other protocol ID number	N0544122074
This trial has been approved by an ethics committee
Current trial status	Open (actively recruiting new participants)
First subject enrolment Target N. of subjects	01/2003 30
Major Disease (ICD9 class)	ATTENTION DEFICIT DISORDER OF CHILDHOOD
Experimental drug
Methylphenidate Treatment regimen (dosage and duration) N/A
Gender	Male
Age (range)	7-13 years
Eligibility criteria
Inclusion criteria
Diagnosed with Attention deficit disorder.
Exclusion criteria
Previously had Methylphenidate
Trial design/methodology
Phase	3
Kind of study	Efficacy Safety
Design	Controlled Randomised Blinded Double blind
Purpose of study
To investigate effects of Methylphenidate on decision-making, response inhibition and delay processing in seven to thirteen year old boys diagnosed with ADHD. Furthermore, the project will examine relationships between the identified cognitive abnormalities and clinical/ behavioural symptoms.
Primary outcomes
Effects of Methylphenidate on decision-making, response inhibition and delay processing.
Secondary outcomes
To clarify the nature of, and the relationships between, neurochemical, cognitive and behavioural phenotypes of this disorder.
Summary of study design, objectives, and ongoing research findings
Double-blind, placebo-controlled study to investigate the effects of Methylphenidate on decision-making, response inhibition and delay processing in seven to thirteen year old boys with ADHD. The project also aims to clarify the nature of, and the relationships between, neurochemical, cognitive and behavioural phenotypes of this disorder.